Management of Patients with Recurrent Vulvovaginal Candidiasis

Author： Sobel J.D.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.11, 2003-01, pp. : 1059-1066

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maintenance suppressive azole antifungal regimens are a major advance in controlling recurrent vulvovaginal candidiasis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 7, 2004-07 ,pp. : 7-11

Adis International

Access to resources Recommend Favorite

Fluconazole in vulvovaginal candidiasis: control not cure

By  

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Management of Invasive Candidiasis in Critically Ill Patients

By Stijn Blot   Koenraad Vandewoude  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2159-2175

Adis International

Access to resources Recommend Favorite

Itraconazole and fluconazole are comparable for the treatment of acute vaginal or vulvovaginal candidiasis in nonpregnant women

By  

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Oesophageal Candidiasis in Elderly Patients: Risk Factors, Prevention and Management

By Weerasuriya Namal   Snape Jeremy  

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 119-130

Adis International

Access to resources Recommend Favorite